JPH037584A - Production of acci restriction endonuclease - Google Patents

Production of acci restriction endonuclease

Info

Publication number
JPH037584A
JPH037584A JP1143359A JP14335989A JPH037584A JP H037584 A JPH037584 A JP H037584A JP 1143359 A JP1143359 A JP 1143359A JP 14335989 A JP14335989 A JP 14335989A JP H037584 A JPH037584 A JP H037584A
Authority
JP
Japan
Prior art keywords
restriction endonuclease
acci restriction
plasmid
host
dna fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1143359A
Other languages
Japanese (ja)
Other versions
JP2518051B2 (en
Inventor
Fumikiyo Kawakami
文清 川上
Yoshihiko Maekawa
前川 宜彦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP1143359A priority Critical patent/JP2518051B2/en
Publication of JPH037584A publication Critical patent/JPH037584A/en
Application granted granted Critical
Publication of JP2518051B2 publication Critical patent/JP2518051B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To easily obtain the title endonuclease by transforming a host with recombinant plasmid incorporated with chromosome DNA fragment containing AccI restriction endonuclease gene of specific microorganism origin followed by culturing and then collecting the enzyme produced. CONSTITUTION:Chromosome DNA fragment containing AccI restriction endonuclease gene of Acinetobacter calcoaceticus origin is incorporated into plasmid, and using the resultant recombinant plasmid, host (e.g. Escherichia coli) is transformed and the resultant host is cultured to produce AccI restriction endonuclease. Thence, the objective AccI restriction endonuclease is collected from the cultured product. Thereby, mass production of the objective AccI restriction endonuclease can be easily accomplished without the need for removing both AccII and AccIII restriction endonucleases because of effecting no production thereof.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明はAce I制限エンドヌクレアーゼの遺伝子を
含む染色体DNA断片を組み込んでなる新しい組換えプ
ラスミド、該プラスミドを導入して形質転換した宿主及
び該宿主を培養してAce I制限エンドヌクレアーゼ
を製造する方法に関する。
Detailed Description of the Invention (Industrial Application Field) The present invention relates to a new recombinant plasmid incorporating a chromosomal DNA fragment containing the Ace I restriction endonuclease gene, a host transformed by introducing the plasmid, and a host transformed with the plasmid. The present invention relates to a method for producing Ace I restriction endonuclease by culturing a host.

(従来の技術) ■型制限酵素はデオキシリボ核酸(DNA)tN中のあ
る特定の塩基配列を認識し、これを切断する極めで特異
性の高い酵素であり、このすぐれた特異性により遺伝子
工学の分野で幅広く利用されている。
(Prior art) Type 1 restriction enzymes are highly specific enzymes that recognize and cleave a specific base sequence in deoxyribonucleic acid (DNA) tN. It is widely used in various fields.

現在までのところ、細面等から約100種類の■型制限
酵素が発見され、商品化されている。本発明のAce 
1 m限エンドヌクレアーゼも、この■型制限酵素のひ
とつであり、DNAの塩基配列中のΦ GT AGCTCTを認識し、これを切断する酵素であ
り、アシネトバクタ−カルコアセチカス(Acinet
obacfer cafcoaceticus)におい
て生産されることが知られている(Nucleic A
c1ds Re5earch L1r16s(1985
))  。
To date, approximately 100 types of type restriction enzymes have been discovered and commercialized from small surfaces. Ace of the present invention
1m-limited endonuclease is also one of these ■-type restriction enzymes, and is an enzyme that recognizes and cleaves Φ GT AGCTCT in the base sequence of DNA.
obacfer cafecoaceticus) (Nucleic A
c1ds Re5earch L1r16s (1985
)).

■型制限酵素を遺伝子工学の分野で利用するには最低限
衣の4つの条件を満足する必要がある。
In order to use type restriction enzymes in the field of genetic engineering, it is necessary to satisfy at least four conditions.

すなわち ■他の制限酵素を含まない。That is, ■ Contains no other restriction enzymes.

■フォ゛スファターゼを含まない。■Does not contain phosphatase.

■非特異的DNaseを含まない。■Contains no non-specific DNase.

■3′および5I−エキソヌクレアーゼを含まない。■ Does not contain 3' and 5I-exonuclease.

であり、そのため市販されている制限酵素は除核酸法、
塩析法、ゲル濾過法、イオン交換クロマトグラフィー法
、アフィニティークロマトグラフィー法等を組み合わせ
ることにより高純度に精製されている0本発明のAcc
 r制限エンドヌクレアーゼについても、他の制限酵素
と同様の方法が試みられたが、特にAce I制限エン
ドヌクレアーゼにおいては、アシネトバクタ−カルコア
セチ力、ス(Acinetobacter calco
aceticus)はAce I制限エンドヌクレアー
ゼ以外にCG CGをv!alIliシ、これを切φ 断する制限酵素、Qcc I!及びT CCGGAを認
識し、これを切断する制限酵素、Acc mをも同時に
生産するため、これを除くことが非常に困難であった。
Therefore, commercially available restriction enzymes are
The Acc of the present invention is purified to a high purity by a combination of salting-out method, gel filtration method, ion exchange chromatography method, affinity chromatography method, etc.
The same method as for other restriction enzymes has been attempted for Ace I restriction endonuclease, but especially for Ace I restriction endonuclease, Ace
aceticus) uses CG CG in addition to Ace I restriction endonuclease. alIli, the restriction enzyme that cuts this, Qcc I! It was extremely difficult to eliminate this enzyme because it simultaneously produced Accm, a restriction enzyme that recognizes and cleaves TCCGGA and TCCGGA.

(発明の解決しようとする課題) 本発明者らは、上記方法の欠点である^ccI[制限エ
ンドヌクレアーゼ及び^ccT[(制限エンドヌクレア
ーゼを同時に生産するという点を解消し、Acc I制
限エンドヌクレアーゼだけを産生ずる菌株を造成すべ(
鋭意研究を行なった。その結果、前記アシネトバクタ−
カルコアセチカス(Acinetobacter ca
lcoaceticus)からAcc I制限エンドヌ
クレアーゼの遺伝子を含む染色体tlNへ断片を抽出し
、これをベクターに組み込んで組換えプラスミドを作成
し、該プラスミドの導入により形質転換させた宿主を得
るに成功するとともに、該宿主が11cc ! @限エ
ンドヌクレアーゼだけを生産するという事実を発見した
0本発明はこの新しい知見に基づいて完成されたもので
ある。
(Problems to be Solved by the Invention) The present inventors solved the drawback of the above method in that ^ccI [restriction endonuclease] and ^ccT[(restriction endonuclease) are simultaneously produced, and Create a strain that produces only
I conducted extensive research. As a result, the Acinetobacter
Acinetobacter ca
lcoaceticus) to the chromosome tIN containing the Acc I restriction endonuclease gene, inserted this into a vector to create a recombinant plasmid, and succeeded in obtaining a transformed host by introducing the plasmid. The host is 11cc! The present invention was completed based on this new knowledge.

(課題を解決する手段) 即ち、本発明はアシネトバクタ−カルコアセチカス(A
cinetobacter calcoacetiqu
s)由来のAcc I制限エンドヌクレアーゼ遺伝子を
含む染色体DNA断片を組み込んだ組換えプラスミド、
該プラスミドで形質転換された宿主及び、該宿主を培養
して、該培養物からAcc I制限エンドヌクレアーゼ
を採取することを特徴とするへcal制限エンドヌクレ
アーゼの製造方法である。
(Means for Solving the Problems) That is, the present invention provides Acinetobacter calcoaceticus (A
cinetobacter calcoacetiqu
a recombinant plasmid incorporating a chromosomal DNA fragment containing the Acc I restriction endonuclease gene derived from s);
A method for producing Hecal restriction endonuclease, which comprises a host transformed with the plasmid, and culturing the host, and collecting Acc I restriction endonuclease from the culture.

本発明の上記組換えプラスミド及びこれを導入した宿主
はAcc I制限エンドヌクレアーゼだけを生産するた
め、その精製工程においてへcclI制限エンドヌクレ
アーゼ及びAce m制限エンドヌクレアーゼを除去す
る必要がなく、大量のAcc 1制限エンドヌクレアー
ゼを容易に製造することが可能となった。
Since the recombinant plasmid of the present invention and the host into which it is introduced produce only Acc I restriction endonuclease, there is no need to remove Acc I restriction endonuclease and Ace m restriction endonuclease in the purification process, and a large amount of Acc 1 restriction endonuclease can now be easily produced.

以下本発明につき詳細に説明する。The present invention will be explained in detail below.

(a)  プラスミド及びその調製 本発明の組換えプラスミドは、例えば、エシェリヒア属
に属する微生物の染色体外遺伝子(プラスミド)として
知られるコリシンEl因子等の、培養された細胞内で増
殖し1うる形式をとるプラスミドに、アシネトバクタ−
カルコアセチカス(Acinetobacter ca
lcoaceticus)由来のAcc I制限エンド
ヌクレアーゼ遺伝子を含む[lN^断片を組み込んでな
るプラスミドである。
(a) Plasmids and their preparation The recombinant plasmids of the present invention contain forms that can proliferate in cultured cells, such as the colicin El factor, which is known as an extrachromosomal gene (plasmid) of microorganisms belonging to the genus Escherichia. Acinetobacter is added to the plasmid to be taken.
Acinetobacter ca
This is a plasmid that incorporates the [lN^ fragment] containing the Acc I restriction endonuclease gene derived from P. lcoaceticus.

前記ベクターDNAとしては、天然に存在するものを抽
出したものの他、増殖に必須な部分以外のDNAの部分
が一部欠落しているものでもよく、例えばCo1B、の
系統、pMB9の系統、pBR322の系統、pscl
olの系統、R6にの系統、ラムダ−ファージの系統等
が挙げられる。
The vector DNA may be one extracted from naturally occurring DNA or one in which part of the DNA other than the part essential for proliferation is missing, such as Co1B strain, pMB9 strain, pBR322 strain, etc. strain, pscl
Examples include the ol strain, the R6 strain, and the lambda phage strain.

また前記ベクターDNAに前記染色体DNA断片を組み
込む方法は、既知のいずれの方法も適用しうる0例えば
、適当な制限酵素(Endonuclease)で処理
して染色体DNAを特定部位で切断し、次いで同様に処
理したベクターDNAと混合し、リガーゼによって再結
合する方法が用いられる。
In addition, any known method can be used to incorporate the chromosomal DNA fragment into the vector DNA. For example, chromosomal DNA is cut at a specific site by treatment with an appropriate restriction enzyme (Endonuclease), and then treated in the same manner. A method is used in which the vector DNA is mixed with the vector DNA and religated using ligase.

ベクターDNAとして、pUc19プラスミドを用い、
これにアシネトバクタ−カルコアセチカス(Acine
tobacter calcoacaticus)から
調整された染色体DNA断片を組み込むことにより、新
規プラスミドpAcc I RM 8が得られる。
Using pUc19 plasmid as vector DNA,
This is supplemented by Acinetobacter calcoaceticus (Acinetobacter calcoaceticus).
A novel plasmid pAcc I RM 8 is obtained by incorporating a chromosomal DNA fragment prepared from Tobacter calcoacaticus).

pAcc I RM 8プラスミドの調整工程及び制限
酵素地図を第1図に示す、第1図から明らかなように、
このプラスミドはpUc19プラスミドの制限酵素サイ
トのBam+Hzサイトに、アシネトバクタ−カルコア
セチカス(Acinetobacter calcoa
ceticus)のAce I制限エンドヌクレアーゼ
遺伝子を含むDNA断片が組み込まれた8kbの塩基対
を有する円形分子である。
The preparation process and restriction enzyme map of the pAcc I RM 8 plasmid are shown in FIG. 1. As is clear from FIG.
This plasmid contains Acinetobacter calcoaceticus (Acinetobacter calcoaceticus) at the Bam+Hz site of the restriction enzyme site of the pUc19 plasmid
It is a circular molecule with 8 kb base pairs into which a DNA fragment containing the Ace I restriction endonuclease gene of S. ceticus has been incorporated.

Φ) 微生物の調製 このようにして得られた前記染色体DNA断片とベクタ
ーDNAの結合物を既ち形質転換法、例えばシッット・
ガン法(shot gun method)により受容
菌の微生物菌体中に導入すると、所望の遺伝形質とベク
ターDNAの形質を併わせもつ形質転換株が得られる。
Φ) Preparation of microorganisms The conjugate of the chromosomal DNA fragment and vector DNA obtained in this way is subjected to a transformation method, such as sit-transformation.
When introduced into a recipient microbial cell by the shot gun method, a transformed strain having both the desired genetic traits and the traits of the vector DNA can be obtained.

受容菌としては、前記のエシェリヒア・コリDB101
、同C600、同DP、 5upF、同x1776、同
LH392等の通常この種の技術分野で用いられる微生
物が有利に用いられる。その典型的な例としてエシェリ
ヒア・コIJFIBIOI株が挙げられる〔モレキュラ
ー・クローニング・エイ・ラボラトリ−・マニュアル、
(Molecular  Cloning A Lab
oratory Manual P、504(19B2
) 参照;遺伝形質F−2hsd s20 (r−1+1l
l−1) reCA13、ara、14、pro A2
、facYl、gal K2、rps L20(Sm’
)、xyl−5、+*tj!−1、sup E44λ−
)〕。
The recipient bacteria include the aforementioned Escherichia coli DB101.
, C600, DP, 5upF, x1776, LH392, etc., which are commonly used in this type of technical field, are advantageously used. A typical example is the Escherichia coIJFIBIOI strain [Molecular Cloning A Laboratory Manual,
(Molecular Cloning A Lab
oratory Manual P, 504 (19B2
) Reference; genetic trait F-2hsd s20 (r-1+1l
l-1) reCA13, ara, 14, pro A2
, facYl, gal K2, rps L20 (Sm'
), xyl-5, +*tj! -1, sup E44λ-
)].

このエシェリヒア・コリ■BIOI株に、前記プラスミ
ドpAcc I RM8を導入して形質転換法により得
られる微生物ば、新規微生物であり、エシェリヒア・コ
リHBIOI(pAcc IRM8) (Escher
ichia Co11HBIOI(pAcc I RM
8) )と呼称され、平成元年5月25日付にて工業技
術院微生物工業技術研究所へ寄託され、その寄託番号は
、微工研菌寄第10740号(FERM P−1074
0)である、このようにして得られたエシェリヒア・コ
リHBIOI(pAcc T RM8)の菌学的性質を
、DNA受容菌であるエシェリヒア・コIJtIBIO
I株の性質を比較すると、前者がAcc I制限エンド
ヌクレアーゼの生産能及びアンピシリン耐性を有するの
に対し、後者がこれらの特性を有しない点以外は、全く
同一である。
The microorganism obtained by the transformation method by introducing the plasmid pAcc I RM8 into this Escherichia coli BIOI strain is a new microorganism, and Escherichia coli HBIOI (pAcc IRM8) (Escher
ichia Co11HBIOI (pAcc I RM
8)) and was deposited with the Institute of Microbiology, Agency of Industrial Science and Technology on May 25, 1989, and its deposit number is FERM P-10740 (FERM P-1074).
The mycological properties of Escherichia coli HBIOI (pAcc T RM8) obtained in this way, which is
Comparing the properties of the I strains, they are completely identical except that the former has the ability to produce Acc I restriction endonuclease and ampicillin resistance, whereas the latter does not have these properties.

(C)  制限エンドヌクレアーゼの生産工程(b)で
得られた形質転換株を培養するには、特定の遺伝情報に
よって生成される物質の生産に適した培地であって且つ
宿主微生物の生育に適した培地を用い得るが、本発明方
法では、通常、エシェリヒア・コリの生育培地として用
いられるLB培地(トリプトン、酵母エキス、食塩) 
、BPB培地(Dirco ; ポリペプトン、酵母エ
キス、リン酸カリウム)、栄養・寒天、培地(Dirc
o 0001 ) トリプトン・食塩培地等を基本培地
として調製したものを用いればよい。
(C) To culture the transformed strain obtained in the restriction endonuclease production step (b), use a medium suitable for the production of the substance produced by specific genetic information and suitable for the growth of the host microorganism. However, in the method of the present invention, LB medium (tryptone, yeast extract, salt), which is usually used as a growth medium for Escherichia coli, can be used.
, BPB medium (Dirco; polypeptone, yeast extract, potassium phosphate), nutrients/agar, medium (Dirc
o 0001) A tryptone/salt medium or the like prepared as a basic medium may be used.

その他、必要に応じて炭素源・窒素源の他にアミノ酸、
ビタミン等の栄養素を添加してもよい。
In addition to carbon and nitrogen sources, amino acids,
Nutrients such as vitamins may be added.

培養方法は、pH、温度、酸素供給量等の条件として通
常のエシェリヒア属の微生物の生育に適した条件を採り
得るが、前記微生物を培地に接種した後、前記微生物が
生育してその菌体量が最大に達したとき、即ち対数増殖
後期まで生育させるのが好ましい、培養温度は、通常3
0〜37°C,pH条件は、p)15〜8の範囲、特に
中性付近が適当である。
The culture method can use conditions such as pH, temperature, and oxygen supply that are suitable for the growth of normal Escherichia microorganisms. It is preferable to grow until the maximum amount is reached, that is, to the late stage of logarithmic growth, and the culture temperature is usually 3.
The suitable pH conditions are p) 15 to 8, particularly around neutrality.

得られた菌体を集菌後、遠心分離、超音波破砕工程等に
より抽出し、次いで除核酸法、塩析法・ゲル濾過法、イ
オン交換クロマトグラフィー法、アフィニティクロマト
グラフィー法等を組み合わせることによりAcc I制
限エンドヌクレアーゼを得ることができる。
After collecting the obtained bacterial cells, they are extracted by centrifugation, ultrasonic disruption, etc., and then by combining nucleic acid removal method, salting out method/gel filtration method, ion exchange chromatography method, affinity chromatography method, etc. Acc I restriction endonuclease can be obtained.

(発明の効果) 本発明のプラスミド及びこれを導入した形質転換株はA
ce I制限エンドヌクレアーゼだけを生産するため、
その精製工程において、Acc II制限エンドヌクレ
アーゼ及びAcc m制限エンドヌクレアーゼを除去す
る必要がなく、これにより大量のへcal制限エンドヌ
クレアーゼを容易に製造することが可能となった。
(Effect of the invention) The plasmid of the present invention and the transformed strain into which it is introduced are A
To produce only ce I restriction endonuclease,
In the purification process, there is no need to remove Acc II restriction endonuclease and Acc m restriction endonuclease, which makes it possible to easily produce a large amount of hecal restriction endonuclease.

以下本発明を実施例により、更に詳細に説明するが、本
発明は何らこれらに限定されるものではない。
EXAMPLES The present invention will be explained in more detail below with reference to Examples, but the present invention is not limited thereto.

実施例1 (1)  Accl制限エンドヌクレアーゼの遺伝子を
もつ染色体[INAの調製 アシネトバクタ−カルコアセチカス(Acinet。
Example 1 (1) Preparation of chromosome [INA] carrying the gene for Accl restriction endonuclease Acinetobacter calcoaceticus (Acinet).

bacter calcoaceticus)をL−b
roth培地〔純粋11あたりトリプトン(Dirco
) 10 g−、酵母エキス5 g 、 NaCl L
ogをpH7,0に調製したもの)50dに接種し、3
0℃で振盪培養を行なった。14時間後に菌体を集めた
0次に集めた菌体を10■/成のリゾチーム〔太陽化学
■製〕、20%シーII!、1 nM EDTAを含む
50mM )リス塩酸緩衝液(pH7,6)20dに懸
濁し、37℃で10分間静置した0次に1%ラウロイル
サルコシン酸を含む0.1M EDT溶液(pH9,6
)44d及び5.44■/IIiのプロナーゼ溶液2.
0 mを加え、50°Cで30分間静置した。
bacter calcoaceticus)
Roth medium [Pure 11 per tryptone (Dirco
) 10 g-, yeast extract 5 g, NaCl L
og adjusted to pH 7.0) inoculated into 50d,
Shaking culture was performed at 0°C. After 14 hours, the bacterial cells collected at the 0th stage were mixed with 10 μ/ml of lysozyme [manufactured by Taiyo Kagaku ■] and 20% Sea II! , 50mM containing 1nM EDTA) was suspended in 20d of Lis-HCl buffer (pH 7,6) and allowed to stand at 37°C for 10 minutes.
) 44d and 5.44■/IIi pronase solution 2.
0 m was added and left at 50°C for 30 minutes.

次に塩化セシウム66g、10■/dのエチジウムブロ
マイド溶液3.3dを加え、混合した後に38.00O
rpm 40時間の遠心分離を行なった。oia層を注
射器で抜きとり、n−ブタノール抽出によってエチジウ
ムブロマイドを除去し、1 mM EDTAを含む10
5M )リス塩酸緩衝液(pH8,0)に透析すること
により約380μgの染色体DNAを取得した。
Next, 66 g of cesium chloride and 3.3 d of ethidium bromide solution of 10 μ/d were added, and after mixing, 38.00 O
Centrifugation was performed at rpm for 40 hours. The OIA layer was removed with a syringe, ethidium bromide was removed by n-butanol extraction, and 100% solution containing 1 mM EDTA was added.
Approximately 380 μg of chromosomal DNA was obtained by dialysis against 5M) Lis-HCl buffer (pH 8,0).

(2)  染色体DNA断片のベクターへの挿入(1)
で得られた染色体DNA 3μgについて0.02ユニ
ツトの5au3^I制限エンドヌクレアーゼを加え、3
7℃1時間の反応を行なうことにより、これを部分分解
した。
(2) Insertion of chromosomal DNA fragment into vector (1)
Add 0.02 units of 5au3^I restriction endonuclease to 3 μg of the chromosomal DNA obtained in
This was partially decomposed by carrying out a reaction at 7°C for 1 hour.

次にベクタープラスミドpUc19 (東洋紡績■製]
1μgについて、4ユニツトのBamHI制限エンドヌ
クレアーゼを加え、37°C1時間の反応を行なうこと
によりこれを完全分解し、更に1ユニツトのアルカリフ
ォファターゼを加え、37°C11時間の反応を行なう
ことにより、5゛末端のリン酸を除去した。
Next, vector plasmid pUc19 (manufactured by Toyobo ■)
For 1 μg, 4 units of BamHI restriction endonuclease were added and the reaction was carried out for 1 hour at 37°C to completely decompose it. Furthermore, 1 unit of alkaline phophatase was added and the reaction was carried out for 11 hours at 37°C. The 5' terminal phosphoric acid was removed.

以上の方法により得られた3μgの染色体[INA断片
と1MgのpBR322のDNA断片を混合し、更に1
mMATP及び5mMジチオスレイトールの存在下に5
ユニツトのT4ファージ由来のDNAIJガーゼを用い
て15°C516時間の連結反応を行なうことにより染
色体DNAを組み込んだプラスミドDNAを取得した。
Mix 3 μg of chromosome [INA fragment obtained by the above method and 1 Mg of pBR322 DNA fragment, and add 1
5 in the presence of mMATP and 5mM dithiothreitol.
Plasmid DNA incorporating chromosomal DNA was obtained by carrying out a ligation reaction at 15°C for 516 hours using DNAIJ gauze derived from UNIT's T4 phage.

(3)  Accl制限エンドヌクレアーゼ遺伝子を含
む組換えプラスミドによる形質転換 エシェリヒア・コリに一12株とエシェリヒア・398
株のハイブリッド株であるエシェリヒア・117881
01株(インビトロジエン社製)をLB培地〔純水12
あたりトリプトン(Dirco)10 g、酵母エキス
5 g 5NaCI LogをpH1,0に調製したち
の10−に接種し、37゛Cで振盪培養行ない、対数増
殖期まで生育させた後に集菌した。これを水冷下、最終
濃度で0.03M CaC1□の溶液に懸濁させてコン
ピテントな細胞とした。この細胞混濁液に(2)で得た
プラスミド1)HAの溶解液を加えて、水冷下で60分
反応させ、42°C,1〜2分間ヒートシロツクを与え
て、前記プラスミドDN^を細胞内に取りこませた0次
いでこの細胞懸濁液を別途前記LB培地に接種し、37
°C13〜5時間振盪培養して形質転換反応行なった後
、アンピシリン耐性を有し、且つへccl制限エンドヌ
クレアーゼを生産する株を分離し、エシェリヒア・コリ
HBIOI (pAcc  [RM8)(微工研菌寄第
1Q’740号)を得た。
(3) Transformation with a recombinant plasmid containing the Accl restriction endonuclease gene Escherichia coli strain 112 and Escherichia 398
Escherichia 117881, a hybrid strain of the strain
01 strain (manufactured by Invitrogen) in LB medium [pure water 12
10 g of tryptone (Dirco), 5 g of yeast extract, and 5 NaCI Log were inoculated into a 10-ml strain prepared to pH 1.0, cultured with shaking at 37°C, and grown to the logarithmic phase, followed by harvesting. This was suspended in a solution with a final concentration of 0.03M CaCl□ under water cooling to obtain competent cells. Add the solution of plasmid 1) HA obtained in (2) to this cell suspension, react for 60 minutes under water cooling, and apply heat syrup at 42°C for 1 to 2 minutes to transfer the plasmid DN^ into the cells. Then, this cell suspension was separately inoculated into the LB medium, and 37
After performing a transformation reaction by culturing with shaking for 13 to 5 hours at °C, a strain having ampicillin resistance and producing ccl restriction endonuclease was isolated, and Escherichia coli HBIOI (pAcc [RM8) 1Q'740).

(4)  エシェリヒア・コ’J HBIOI(pAc
c I RM8)によるAcc 1制限エンドヌクレア
ーゼの生産(3)で得られた形質転換株エシェリヒア・
コリHBIOI(pAcc I RM8) (微工研菌
寄第10740号)を前記LB培地500 dを含む2
1容のフラスコで37°C116時間振盪培養を行なワ
た。これを遠心分離にて集菌、洗浄後、lO+*M M
gC1□、71IIM2−メルカプトエタノールを含ん
だ20mMのトリス塩酸緩衝液(pH7,5) 25m
に懸濁し、0°Cで10分間の超音波破砕を行なった。
(4) Escherichia co'J HBOI (pAc
Production of Acc 1 restriction endonuclease using c I RM8) (3)
Coli HBOI (pAcc I RM8) (Feikoken Bibori No. 10740) was added to the LB medium containing 500 d of the above.
Culture was carried out with shaking at 37°C for 116 hours in a 1-volume flask. The bacteria were collected by centrifugation, and after washing, 1O+*M M
gC1□, 71IIM2-20mM Tris-HCl buffer (pH 7,5) containing mercaptoethanol 25m
The suspension was suspended in water and subjected to ultrasonic disruption at 0°C for 10 minutes.

更に12.000rp−で10分間の遠心分離により酵
素抽出液を得た。
Further, an enzyme extract was obtained by centrifugation at 12,000 rpm for 10 minutes.

次にこの酵素抽出液に硫安粉末を水冷下添加溶解し、3
0〜80%飽和画分を(飽和度は0sborne法で表
示)を遠心分離により回収した。この回収沈澱物を2m
Mメルカプトエタノール、5%グリセロルーを含んだ1
0mMIJン酸緩衝液(pH7,5) ’2 rtdl
に溶解し、更に透析チューブに入れて、100倍量の同
緩衝液に対して1液透析した。続いて同緩衝液にて平衡
化したホスホセルロース(ワットマン社製)のカラム(
容量20−)に吸着させた。5倍量の同緩衝液で洗浄後
0−1.0M MCIグラジェント溶出を行なった。B
an1[I制限エンドヌクレアーゼはMCI濃度0.5
M付近で溶出された。溶出した酵素液を透析チューブに
入れ、2mMメルカプトエタノール、50%グリセロー
ルを含んだリン酸緩衝液に透析することにより5戚の酵
素液が得られた。得られた酵素液の酵素活性を測定した
ところ500ユニツトであった。
Next, ammonium sulfate powder was added and dissolved in this enzyme extract under water cooling.
A 0 to 80% saturated fraction (the degree of saturation is expressed by the 0sborne method) was collected by centrifugation. 2 m of this collected sediment
M mercaptoethanol, 1 containing 5% glycerol
0mMIJ acid buffer (pH 7,5) '2 rtdl
The solution was dissolved in a dialysis tube, and the solution was dialyzed against 100 times the volume of the same buffer. Next, a column of phosphocellulose (Whatman) equilibrated with the same buffer (
Capacity 20-) was adsorbed. After washing with 5 times the volume of the same buffer, 0-1.0M MCI gradient elution was performed. B
an1[I restriction endonuclease was used at an MCI concentration of 0.5
It was eluted around M. The eluted enzyme solution was put into a dialysis tube and dialyzed against a phosphate buffer containing 2mM mercaptoethanol and 50% glycerol to obtain an enzyme solution of the 5th relative. The enzyme activity of the obtained enzyme solution was measured and found to be 500 units.

この様にして得られた酵素液は他の制限エンドヌクレア
ーゼ、フォスファターゼ、非特異的DNaseなどを含
んでおらず遺伝子工学の分野で利用することが可能であ
った。
The enzyme solution thus obtained did not contain other restriction endonucleases, phosphatases, non-specific DNase, etc., and could be used in the field of genetic engineering.

なお、Ace l制限エンドヌクレアーゼの活性の測定
は、1μgのλ−DNAを20++M トリス塩酸緩衝
液、10+M塩化マグネシウム溶液、50mM硫酸アン
モニウム、7 mM 2−メルカプトエタノールからな
る反応液45μ2に溶解し、その混合液に5μ2の酵素
液を加えて、37°Cで1時間の反応を行なった後、ア
ガロース電気泳動を行なうことにより測定する。
The activity of Acel restriction endonuclease was measured by dissolving 1 μg of λ-DNA in 45 μ2 of a reaction solution consisting of 20++M Tris-HCl buffer, 10+M magnesium chloride solution, 50mM ammonium sulfate, and 7mM 2-mercaptoethanol, and mixing the mixture. After adding 5μ2 of the enzyme solution to the solution and performing a reaction at 37°C for 1 hour, the measurement is performed by performing agarose electrophoresis.

酵素活性における1単位は、37°(pH7,5におい
て1時間に1μgのλ−DNAを完全に分解する酵素活
性をいう。
One unit of enzyme activity refers to the enzyme activity that completely degrades 1 μg of λ-DNA in 1 hour at 37° (pH 7.5).

【図面の簡単な説明】[Brief explanation of drawings]

第1図はpAcc I RM8の調製工程および制限酵
素地図を示す。
Figure 1 shows the preparation steps and restriction enzyme map of pAcc I RM8.

Claims (3)

【特許請求の範囲】[Claims] (1)アシネトバクターカルコアセチカス(Acine
tobacter calcoaceticus)由来
のAccI制限エンドヌクレアーゼ遺伝子を含む染色体
DNA断片を組み込んだ組換えプラスミド。
(1) Acinetobacter calcoaceticus (Acine
A recombinant plasmid incorporating a chromosomal DNA fragment containing the AccI restriction endonuclease gene derived from Tobacter calcoaceticus.
(2)アシネトバクターカルコアセチカス(Acine
tobacter calcoaceticus)由来
のAccI制限エンドヌクレアーゼ遺伝子を含む染色体
DNA断片を組み込んだ組換えプラスミドで形質転換さ
れた宿主。
(2) Acinetobacter calcoaceticus (Acine
A host transformed with a recombinant plasmid incorporating a chromosomal DNA fragment containing the AccI restriction endonuclease gene derived from Tobacter calcoaceticus.
(3)アシネトバクターカルコアセチカス(Acine
tobacter calcoaceticus)由来
のAccI制限エンドヌクレアーゼ遺伝子を含む染色体
DNA断片を組み込んだ組換えプラスミドで形質転換さ
れた宿主を培養して、該培養物からAccI制限エンド
ヌクレアーゼを採取することを特徴とするAccI制限
エンドヌクレアーゼの製造方法。
(3) Acinetobacter calcoaceticus (Acine
AccI restriction method comprising culturing a host transformed with a recombinant plasmid incorporating a chromosomal DNA fragment containing the AccI restriction endonuclease gene derived from Tobacter calcoaceticus) and collecting AccI restriction endonuclease from the culture. Method for producing endonuclease.
JP1143359A 1989-06-06 1989-06-06 Method for producing AccI restricted endonuclease Expired - Lifetime JP2518051B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1143359A JP2518051B2 (en) 1989-06-06 1989-06-06 Method for producing AccI restricted endonuclease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1143359A JP2518051B2 (en) 1989-06-06 1989-06-06 Method for producing AccI restricted endonuclease

Publications (2)

Publication Number Publication Date
JPH037584A true JPH037584A (en) 1991-01-14
JP2518051B2 JP2518051B2 (en) 1996-07-24

Family

ID=15336953

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1143359A Expired - Lifetime JP2518051B2 (en) 1989-06-06 1989-06-06 Method for producing AccI restricted endonuclease

Country Status (1)

Country Link
JP (1) JP2518051B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034006A1 (en) * 1996-03-13 1997-09-18 Takara Shuzo Co., Ltd. Plasmid
US7603195B2 (en) 2003-11-06 2009-10-13 Applied Materials, Inc. Methods and apparatus for integrating large and small lot electronic device fabrication facilities
US7603196B2 (en) 2004-02-28 2009-10-13 Applied Materials, Inc. Methods and apparatus for material control system interface

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH022366A (en) * 1987-12-17 1990-01-08 New England Biolabs Inc Production of acci restriction endonuclease and methylase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH022366A (en) * 1987-12-17 1990-01-08 New England Biolabs Inc Production of acci restriction endonuclease and methylase

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034006A1 (en) * 1996-03-13 1997-09-18 Takara Shuzo Co., Ltd. Plasmid
US6165749A (en) * 1996-03-13 2000-12-26 Takara Shuzo Co., Ltd. Plasmid
US6770481B1 (en) 1996-03-13 2004-08-03 Takara Shuzo Co., Ltd. Gene isolation method
US7603195B2 (en) 2003-11-06 2009-10-13 Applied Materials, Inc. Methods and apparatus for integrating large and small lot electronic device fabrication facilities
US7603196B2 (en) 2004-02-28 2009-10-13 Applied Materials, Inc. Methods and apparatus for material control system interface

Also Published As

Publication number Publication date
JP2518051B2 (en) 1996-07-24

Similar Documents

Publication Publication Date Title
JPH02242675A (en) purified enzyme
CN110938611A (en) DNA polymerase and preparation method and application thereof
JPS61234784A (en) Transport of deoxyribonucleic acid plasmid to cell host in vivo
CN114230644A (en) GP32 protein mutant, recombinant vector, and construction method and application thereof
JPH02167084A (en) Production of pvui restricted endonuclease
JP2518051B2 (en) Method for producing AccI restricted endonuclease
Dong et al. A single digestion, single-stranded oligonucleotide mediated PCR-independent site-directed mutagenesis method
JP2587764B2 (en) Method for producing N-acylneuraminic acid aldolase
US4376164A (en) Process for preparing broad host range small plasmid rings as cloning vehicles
JPS62126972A (en) Novel restriction enzyme and production thereof
US4418194A (en) DNA Fragments for forming plasmids
US4259446A (en) Process for preparation of deoxyribonucleases
CN116286743B (en) A medium-temperature nuclease mutant protein and its preparation method and application
JPH0630576B2 (en) Method for producing Ban I restriction endonuclease
JPH0630577B2 (en) Ban III-Method for producing restriction endonuclease
JPH02255086A (en) Novel restriction enzyme and production thereof
CN120608036A (en) Thermostable single-stranded DNA/RNA ligase and its application
JPH03112484A (en) Novel restriction enzyme and its production
JPH07121219B2 (en) Method for producing new BamHI restriction endonuclease
JPH0665301B2 (en) Method for producing NAL (N-acylneuraminic acid aldolase)
CN121851114A (en) A thermostable SSB protein mutant
CN104805108A (en) Method for quickly constructing high-copy gene concatemer
JPS62277A (en) Novel plasmid, novel microorganism transformed therewith and production of useful physiologically active substance using same
JPH0198487A (en) Novel plasmid, novel bacterium transformed with said plasmid and enzymatic production of s-lactoylglutathione using said bacterium
JPH0757189B2 (en) Method for producing N-acylneuraminic acid aldolase